Development of the new acellular recombinant pertussis vaccine.
Rappuoli
R
R
Istituto Ricerche Immunobiologiche Siena Biocine Sclavo S.p.A, Italy.
Pizza
M
M
Podda
A
A
De Magistris
M T
MT
Ceccarini
C
C
Nencioni
L
L
D000818:Animals; D001886:Bordetella pertussis / Q000235:genetics / Q000276:immunology; D003001:Cloning, Molecular; D005814:Genes, Viral / Q000235:genetics; D006389:Hemagglutinins, Viral / Q000032:analysis / Q000276:immunology; D006801:Humans; D010567:Pertussis Vaccine / Q000138:chemical synthesis*; D015164:Vaccines, Inactivated / Q000138:chemical synthesis; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella / Q000032:analysis / Q000235:genetics / Q000276:immunology
D006389:Hemagglutinins, Viral; D010567:Pertussis Vaccine; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella